Coronavirus News Highlights from November 25th: When a new variant of Covid was discovered in South Africa, Hong Kong and Botswana, the center issued new information for international travelers

Coronavirus News Highlights from November 25th: When a new variant of Covid was discovered in South Africa, Hong Kong and Botswana, the center issued new information for international travelers

Coronavirus Vaccine Registration, Covid-19 India Latest Update, Coronavirus Cases In India Today’s News, Nov 25 Highlights: Bharat Biotech Says Covaxin Meets WHO Efficacy Criteria For COVID-19 Vaccines For Delta Variant; EU Approves Pfizer’s Covid-19 Vaccine For Children Ages 5-11; Kerala reports 5,987 new infections, 56 deaths

Coronavirus Variants And Vaccinations, Active Coronavirus Cases In India Nov 25 News: Bharat Biotech has stated in a statement that its Covid-19 vaccine Covaxin meets the WHO’s effectiveness criteria for COVID-19 vaccines for the dreaded Delta variant. It did so after the Lancet published the results of an interim study showing that two doses of Covaxin were 77.8% effective against symptomatic disease and had no serious safety concerns.

The Lancet study also found that two doses of Covaxin were 50 percent effective against symptomatic COVID-19. Bharat Biotech said these results compare well with the 65.2% efficacy versus the Delta variant achieved during controlled Phase 3 clinical trials of Covaxin in the general population.

In a statement, Bharat Biotech said: “Bharat Biotech commends the AIIMS researchers for the BBV152 study published in Lancet Infectious Diseases. These results prove the effectiveness of COVAXIN in real life.

A 50% efficacy score obtained during the highest COVID-19 delta variant wave in India in a high risk study population of doctors and nurses in a hospital setting and repeatedly challenged with high viral loads provides insight into the efficacy and effectiveness of COVAXIN.

These results compare favorably with the 65.2% efficacy versus the Delta variant obtained during COVAXIN’s Phase III controlled clinical trials in the general population. This study also shows that COVAXIN meets the WHO efficacy criteria for COVID-19 vaccines for the dreaded Delta variant. “

India reports 9,119 new cases, 10,264 recoveries and 396 deaths in the past 24 hours

Meanwhile, India has reported 9,119 new cases, 10,264 recoveries and 396 deaths in the past 24 hours, according to the Ministry of Health. The current number of active cases is 1.09.940 – the lowest value in 539 days.

Here are the latest and verified updates related to the coronavirus pandemic from India and around the world:

Financial Express is now on Telegram. Click here to join our channel and stay up to date with the latest biz news and updates.

You May Like :